AGENUS INC Deferred Compensation Arrangement with Individual, Shares Issued
AGENUS INC (AGEN) reported Deferred Compensation Arrangement with Individual, Shares Issued of 33.48 thousand shares for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued · last filed 2013-03-18
- AGENUS INC deferred compensation arrangement with individual, shares issued for the quarter ending 2012-12-31 was 479.00 shares.
- AGENUS INC deferred compensation arrangement with individual, shares issued for the quarter ending 2012-09-30 was 0.00 shares.
- AGENUS INC deferred compensation arrangement with individual, shares issued for fiscal 2012 was 33.48K shares.
| Period end | Deferred Compensation Arrangement with Individual, Shares Issued 3 month | Deferred Compensation Arrangement with Individual, Shares Issued 6 month | Deferred Compensation Arrangement with Individual, Shares Issued 9 month | Deferred Compensation Arrangement with Individual, Shares Issued 12 month |
|---|---|---|---|---|
| 2012-12-31 | 479.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 479.00 shares derived: sum of 2 quarters · filed 2013-03-18 | 33.48K shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | 33.00K shares 10-Q · filed 2012-11-07 | ||
| 2012-06-30 | 33.00K shares 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |